血液凝固的修订模型中的XI因子激活
1Department of Medicine, Jewish Hospital, Washington University Medical Center, St. Louis, MO 63110.
概括
热血素,而不是XIIa因子,是体内凝血因子XI的主要激活剂. 这种修订后的凝血模型强调了血素在XI因子激活中的关键作用,影响了出血障碍研究.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 凝血级联是凝血级联的一个过程.
背景情况:
- 凝血因子XI (FXI) 的激活传统上归因于因子XIIa (FXIIa).
- 十二因子缺乏与出血无关,这表明存在一种替代的体内FXI激活途径.
- 高分子量激素 (HMWK) 和负电荷的表面是已知的FXIIa介导的FXI激活的辅因子.
研究的目的:
- 为了研究凝血因子XI激活的体内机制.
- 为凝血级联提出了一个修订后的模型,重点关注FXI激活.
- 为了比较凝血素和FXIIa在激活FXI时的催化效率.
主要方法:
- 试管体内动力学测定测量纯化XI因子通过血栓素和XIIa因子的激活.
- 评估辅助因子的影响,包括硫酸,对血栓介导的FXI激活.
- 对酶动力学 (kcat/Km) 的分析,以确定相对激活效率.
主要成果:
- 热血素在激活FXI时表现出明显更高的催化效率 (kcat/Km = 1.6 x 10^5) 比FXIIa (1.7 x 10^4) 在激活FXI.
- 德克斯硫酸盐可使血栓因子介导的FXI激活大约2000倍.
- 德克斯硫酸盐增强的一部分归因于通过激活的FXI (FXIa) 自动激活FXI.
结论:
- 血栓激素被提议在体内作为凝血因子XI的主要生理激活剂.
- 这种修订后的模型挑战了FXIIa启动内在凝固途径的传统观点.
- 了解血栓素在FXI激活中的作用对于开发出治疗出血障碍的新治疗策略至关重要.
相关概念视频
Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.


